The Division of Vascular Surgery and Endovascular Therapy continues to build upon its over six-decade-long heritage of caring for patients with vascular disease while maintaining the tradition of clinical and research excellence envisioned by its founder, Dr. Michael E. DeBakey.
With a team of more than 15 faculty members, postdoctoral fellows, and graduate students devoted to healthcare and scientific research, the division is committed to discovering new treatments through collaborative and integrated research in the diverse disciplines of surgery, biology, and molecular science.
Our Vascular Surgery Residency has become one of the premier vascular surgery training programs in the country since Drs. Michael DeBakey and Stanley Crawford established it in 1970. This fellowship is a two-year ACGME-approved program. Graduates are eligible for the Certificate of Special Qualifications in Vascular Surgery granted by the American Board of Surgery.
Our clinical program includes eight full-time faculty surgeons working across the medical center and at affiliated institutions. These surgeons have effectively shifted from performing traditional open surgical procedures to minimally invasive endovascular interventions, whenever appropriate. Reflective of this work, division faculty members recently published a paper on the development of a new endovascular technique to treat flush iliac artery occlusions, a daunting challenge to vascular surgeons. This pioneering work, featured at the prestigious Veith Symposium in New York, has been adopted by practitioners all over the world.
Faculty members are widely recognized as leaders in the fields of vascular surgery and endovascular therapy at several institutions in the Texas Medical center, including Baylor St. Luke’s Medical Center, the Texas Heart Institute, Texas Children’s Hospital, the Michael E. DeBakey VA Medical Center, and Ben Taub Hospital.
Our clinical research focuses on new device development and outcomes analysis following surgical or endovascular treatment of aortic aneurysms, dialysis interventions, lower extremity occlusive disease, and carotid disease. These studies have helped define standards of care in vascular disease management. The division also has an active basic science research program located in the Molecular Surgeon Research and Education Center (MSREC). Funded in part by the National Institutes of Health, the MSREC conducts basic science programs in vascular biology and therapeutics.